The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study (FLIPR)

September 20, 2017 updated by: Andrew Hartwick, Ohio State University
This study is designed to investigate whether the pupil response to slowly flashing colored lights is significantly altered in patients with glaucoma, as compared to a control group of subjects without glaucoma.

Study Overview

Status

Completed

Detailed Description

The pupils inside the eyes constrict in response to light stimulation. Different classes of cells within the human retina initiate this response. Recent research suggests that one of the ganglion cell types involved in this pupil response is affected by glaucoma. By measuring pupil responses to different colored lights, the function of this class of cells can be evaluated quickly, and without touching the eye. An advantage of pupil testing strategies is that they do not require subjective feedback from the subject about what they can see, as is required for standard visual field tests that are used in the clinic.

The main aim of this study is to measure and compare the pupil constriction that occurs in response to flickering red and blue lights in patients with glaucoma versus matched control patients without glaucoma. In addition, the subjects will be asked questions about their quality of life and it will be determined whether issues related to quality of life correlate to alterations in the pupil responses.

Study Type

Observational

Enrollment (Actual)

32

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 42310
        • OSU College of Optometry
      • Columbus, Ohio, United States, 43212
        • Havener Eye Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Cases: Age 18 or older with diagnosed glaucoma of known severity Controls: Matched to Cases on age, sex, and race.

Description

Inclusion Criteria:

  • 18+ years old
  • Diagnosed with glaucoma of known severity (cases only)
  • Have a refractive error between +4.00 and -8.00 sphere power, and no more than 3.00 diopters of astigmatism
  • Best corrected visual acuity of 20/40 or better in each eye
  • Have open anterior chamber angles

Exclusion Criteria:

  • Diagnosis of glaucoma of a type other than Primary Open Angle (cases only)
  • History of having surgery or taking medications known to profoundly affect pupillary function or shape
  • Visual Field defect (controls only)
  • History of traumatic brain injury requiring hospitalization
  • Pregnancy
  • History of optic nerve disease other than glaucoma
  • History of retinopathy
  • History of unreactive pupils
  • Presence of significant cataract

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Subjects with glaucoma (Cases)
This group will consist of patients with glaucoma who are under care at the Ohio State University Havener Eye Institute.
Subjects without glaucoma (Controls)
This group will consist of matched controls who are free of glaucoma and other complications, and who received a comprehensive eye examination at the Ohio State University College of Optometry.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pupil Response
Time Frame: Single Visit: One Day
Using fourier analysis, the pupil fluctuation evoked by blue and red flickering lights will be measured in glaucoma patients and compared to matched controls.
Single Visit: One Day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life Survey
Time Frame: Single Visit: One Day
Subjects will fill out a questionnaire with questions that assess quality of life issues, and the results will be correlated to the pupil response data.
Single Visit: One Day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrew Hartwick, OD, PhD, OSU College of Optometry

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Shorter P, Eren D, Jain SG, Hartwick ATE. 2014. The flashing light-induced pupil response (FLIPR) glaucoma study. Invest. Ophthalmol. & Vis. Sci. 55: E-abstract 5608.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2013

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

May 13, 2013

First Submitted That Met QC Criteria

May 15, 2013

First Posted (Estimate)

May 20, 2013

Study Record Updates

Last Update Posted (Actual)

September 25, 2017

Last Update Submitted That Met QC Criteria

September 20, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 2013H0073
  • 8KL2TR000112-05 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glaucoma, Open-Angle

3
Subscribe